| scholarly article | Q13442814 |
| P50 | author | Wanli W Smith | Q90375070 |
| P2093 | author name string | Xiaobo Wang | |
| Christopher A Ross | |||
| Chunfeng Liu | |||
| Fengtian Xue | |||
| Joseph M Thomas | |||
| Frederick C Nucifora | |||
| Leslie G Nucifora | |||
| Zhaohui Liu | |||
| Bingling Dai | |||
| Tianxia Li | |||
| Gongbo Guo | |||
| P2860 | cites work | The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction | Q24292709 |
| Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration | Q24298689 | ||
| Kinase activity of mutant LRRK2 mediates neuronal toxicity | Q24303603 | ||
| Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies | Q24318474 | ||
| Origin and function of ubiquitin-like proteins | Q24651141 | ||
| Non-canonical ubiquitin-based signals for proteasomal degradation | Q26825366 | ||
| Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology | Q28131833 | ||
| The ubiquitin code | Q28265104 | ||
| Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death | Q28287762 | ||
| A novel GTP-binding inhibitor, FX2149, attenuates LRRK2 toxicity in Parkinson's disease models | Q28545100 | ||
| NF-κB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-κB activation | Q33915312 | ||
| Ubiquitin in chains | Q33925675 | ||
| The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution | Q33980214 | ||
| Reevaluation of phosphorylation sites in the Parkinson disease-associated leucine-rich repeat kinase 2 | Q34121655 | ||
| Ubiquitination and selective autophagy | Q34283289 | ||
| The role of ubiquitin in autophagy-dependent protein aggregate processing | Q34347017 | ||
| Non-canonical ubiquitylation: mechanisms and consequences. | Q34348354 | ||
| Assembly and specific recognition of k29- and k33-linked polyubiquitin. | Q34466293 | ||
| Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies | Q35152946 | ||
| Disruption of protein quality control in Parkinson's disease | Q35902695 | ||
| Interplay between Leucine-Rich Repeat Kinase 2 (LRRK2) and p62/SQSTM-1 in Selective Autophagy | Q36133763 | ||
| Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1. | Q36985668 | ||
| CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity | Q37115256 | ||
| A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease | Q37472304 | ||
| Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems | Q37664227 | ||
| Priorities in Parkinson's disease research | Q37870670 | ||
| Role of kinesin-1 in the pathogenesis of SPG10, a rare form of hereditary spastic paraplegia | Q38025542 | ||
| Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. | Q38028343 | ||
| Ubiquitin pathways in neurodegenerative disease | Q38234883 | ||
| α-Synuclein and Lewy pathology in Parkinson's disease | Q38537722 | ||
| LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies. | Q39136594 | ||
| Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models | Q39164937 | ||
| Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases | Q40056959 | ||
| Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation | Q41163700 | ||
| LRRK2 variation and dementia with Lewy bodies | Q41655722 | ||
| LRRK2 dephosphorylation increases its ubiquitination | Q41785779 | ||
| TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains. | Q48125960 | ||
| LRRK2 interferes with aggresome formation for autophagic clearance | Q48647645 | ||
| Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy body pathology | Q61849485 | ||
| P577 | publication date | 2020-03-17 | |
| P1433 | published in | Journal of Cellular Physiology | Q1524270 |
| P1476 | title | GTP-binding inhibitors increase LRRK2-linked ubiquitination and Lewy body-like inclusions |
Search more.